Your partner in science for end-to-end CRDMO solutions
A high-quality, sensitive biomarker can provide crucial insights to project teams throughout the biomarker discovery and development continuum, guiding strategic decisions as projects move towards clinical application.
Biomarker Discovery and Identification
Jubilant Biosys employs a collaborative and adaptable approach to biomarker discovery and validation, ensuring the development of a suitable and robust biomarker tailored to specific objectives. Our extensive expertise includes the identification and validation of pharmacodynamic (PD) biomarkers such as genes, phosphoproteins, and cytokines. Our scientists are proficient in biomarker discovery, identification, and assay development across various therapeutic areas.
Biomarker Analysis
The ability to measure relevant biomarkers with precision and sensitivity is crucial for making critical go/no-go study decisions. Leveraging years of experience in assay design and sample processing, Jubilant Biosys supports pathway-relevant biomarker analysis in discovery programs. We offer analysis via qPCR, traditional Western/JESS, FACS, and other readouts
